A case report and focused literature review of d-penicillamine and severe neutropenia: A serious toxicity from a seldom-used drug

被引：9
作者：
Pitman, Stuart K. [1 ,2 ]
Tony Huynh [1 ]
Bjarnason, Thorarinn A. [3 ]
An, Josiah [3 ]
Malkhasyan, Karen A. [3 ,4 ]
机构：
[1] Univ Iowa Healthcare, Dept Pharmaceut Care, Iowa City, IA USA
[2] Univ Iowa, Coll Pharm, Iowa City, IA 52242 USA
[3] Univ Iowa Healthcare, Iowa City, IA USA
[4] Yale New Haven Med Ctr, New Haven, CT USA
来源：
CLINICAL CASE REPORTS | 2019年 / 7卷 / 05期
关键词：
neutropenia; penicillamine; Wilson's disease; FATAL APLASTIC-ANEMIA; RHEUMATOID-ARTHRITIS; WILSONS-DISEASE; INDUCED AGRANULOCYTOSIS; ADVERSE-REACTIONS; THERAPY; DIAGNOSIS; AZATHIOPRINE;
D O I：
10.1002/ccr3.2125
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Key Clinical Message Prescribing d-penicillamine for Wilson's disease must be accompanied by vigilant monitoring, including a complete blood cell count with differential. For most, this should occur once or twice weekly during the first month of therapy and during periods of dose escalation, then every two weeks for six additional months, then monthly.
引用
收藏
页码：990 / 994
页数：5
相关论文
共 53 条
[1]   Penicillamine, a characteristic degradation product of penicillin [J].
Abraham, EP ;
Chain, E ;
Baker, W ;
Robinson, R .
NATURE, 1943, 151 :107-107
[2]  
[Anonymous], 1987, J Rheumatol, V14, P67
[3]  
[Anonymous], CUPRIMINE PENICILLAM
[4]  
[Anonymous], 2012, DEPEN PEN TABL USP T
[5]  
[Anonymous], 2015, CUPRIMINE PENICILLAM
[6]  
ARNEBORN P, 1982, ACTA MED SCAND, V212, P289
[7]  
CAMP AV, 1981, J RHEUMATOL, V8, P164
[8]   Drug-induced myelosuppression - Diagnosis and management [J].
Carey, PJ .
DRUG SAFETY, 2003, 26 (10) :691-706
[9]  
Committee on Safety of Medicines, 1985, BRIT MED J, V291, P1269
[10]  
CORCOS JM, 1964, JAMA-J AM MED ASSOC, V189, P265
123456